THE AIM ORGANIZATION REPORTS Q3 YEAR-OVER-YEAR REVENUE GROWTH
| Q3 REVENUE INCREASES 45% to $258,810 TO $375,017 |
| The AIM Organization today announced a 45% year-over-year increase in third-quarter revenue, rising from $258,810.20 in Q3 2024 to $375,017.89 in Q3 2025. This sustained growth underscores AIM’s expanding patient numbers, improved patient engagement, and operational efficiency across its multi-site clinical network. The increase was driven by higher patient throughput, expanded service lines—including regenerative and metabolic programs—and booking and show rates. AIM continues to leverage integrated clinical and technology-driven systems to improve both patient outcomes and financial performance. “This growth reflects the hard work of our clinical and administrative teams, as well as our ability to execute on strategy with sound discipline,” said Ralph Lombardo, Chief Executive Officer of the AIM Organization. “We’re continuing to see strong momentum as our programs mature and new initiatives like our GLP Weight Management Program begin to scale.” The organization expects continued top-line expansion in Q4 driven by recently launched weight management services and the integration of AI-based patient engagement systems across locations. About AIM AIM owns and operates a network of profitable clinics, specializing in chronic pain, obesity, and comprehensive ambulatory functions. Known for its innovative approach and patient-centered care, AIM is dedicated to improving patient outcomes and enhancing the quality of life. |
| To Invest or for more information, please contact: David Fann President david.fann@theaimorganization.com 904.251.4910 www.theaimorganization.com |